Luye Pharma Group (02186 HK) released its financial results for the first half of 2019 on August 28 The resul...
Luye Pharma grants AstraZeneca exclusive rights to promote natural lipid-regulating drug Xuezhikang Capsules i...
Australia s most attractive employers announced; Healthe Care ranked 12th alongside Qantas, Apple and Virgin
The pivotal study for Rivastigamine Multi-Day Transdermal Patch (Rivastigamine MD) has been completed in Germa...
Luye Pharma Group has announced submission of a NDA to the U S FDA for Rykindo®
The company has enacted a multi-faceted development plan for sales, R&D, M&A and external collaborations, not ...
TOP